NZ626694B2 - Wound dressing for use in vacuum therapy - Google Patents

Wound dressing for use in vacuum therapy Download PDF

Info

Publication number
NZ626694B2
NZ626694B2 NZ626694A NZ62669412A NZ626694B2 NZ 626694 B2 NZ626694 B2 NZ 626694B2 NZ 626694 A NZ626694 A NZ 626694A NZ 62669412 A NZ62669412 A NZ 62669412A NZ 626694 B2 NZ626694 B2 NZ 626694B2
Authority
NZ
New Zealand
Prior art keywords
yarn
wound
fibres
gel
vacuum
Prior art date
Application number
NZ626694A
Other versions
NZ626694A (en
Inventor
Wayne Bonnefin
Amelia Prentice
Sarah Wroe
Original Assignee
Convatec Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1120693.5A external-priority patent/GB201120693D0/en
Application filed by Convatec Technologies Inc filed Critical Convatec Technologies Inc
Publication of NZ626694A publication Critical patent/NZ626694A/en
Publication of NZ626694B2 publication Critical patent/NZ626694B2/en

Links

Classifications

    • A61F13/00012
    • A61F13/00021
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/00051Accessories for dressings
    • A61F13/00063Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A61F13/00068
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive bandages or dressings
    • A61F13/0203Adhesive bandages or dressings with fluid retention members
    • A61F13/0206Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings
    • A61F13/0209Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings comprising superabsorbent material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00089Wound bandages
    • A61F2013/0017Wound bandages possibility of applying fluid
    • A61F2013/00174Wound bandages possibility of applying fluid possibility of applying pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00089Wound bandages
    • A61F2013/00217Wound bandages not adhering to the wound
    • A61F2013/00229Wound bandages not adhering to the wound with alginate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00089Wound bandages
    • A61F2013/00238Wound bandages characterised by way of knitting or weaving
    • A61F2013/00242Wound bandages characterised by way of knitting or weaving to avoiding fraying or pilling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00365Plasters use
    • A61F2013/00536Plasters use for draining or irrigating wounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00365Plasters use
    • A61F2013/0054Plasters use for deep wounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/60Liquid-swellable gel-forming materials, e.g. super-absorbents
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01GPRELIMINARY TREATMENT OF FIBRES, e.g. FOR SPINNING
    • D01G15/00Carding machines or accessories; Card clothing; Burr-crushing or removing arrangements associated with carding or other preliminary-treatment machines
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01HSPINNING OR TWISTING
    • D01H4/00Open-end spinning machines or arrangements for imparting twist to independently moving fibres separated from slivers; Piecing arrangements therefor; Covering endless core threads with fibres by open-end spinning techniques
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01HSPINNING OR TWISTING
    • D01H4/00Open-end spinning machines or arrangements for imparting twist to independently moving fibres separated from slivers; Piecing arrangements therefor; Covering endless core threads with fibres by open-end spinning techniques
    • D01H4/04Open-end spinning machines or arrangements for imparting twist to independently moving fibres separated from slivers; Piecing arrangements therefor; Covering endless core threads with fibres by open-end spinning techniques imparting twist by contact of fibres with a running surface
    • D01H4/08Rotor spinning, i.e. the running surface being provided by a rotor
    • D01H4/10Rotors
    • DTEXTILES; PAPER
    • D02YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
    • D02GCRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
    • D02G3/00Yarns or threads, e.g. fancy yarns; Processes or apparatus for the production thereof, not otherwise provided for
    • D02G3/02Yarns or threads characterised by the material or by the materials from which they are made
    • DTEXTILES; PAPER
    • D02YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
    • D02GCRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
    • D02G3/00Yarns or threads, e.g. fancy yarns; Processes or apparatus for the production thereof, not otherwise provided for
    • D02G3/02Yarns or threads characterised by the material or by the materials from which they are made
    • D02G3/04Blended or other yarns or threads containing components made from different materials
    • DTEXTILES; PAPER
    • D02YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
    • D02GCRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
    • D02G3/00Yarns or threads, e.g. fancy yarns; Processes or apparatus for the production thereof, not otherwise provided for
    • D02G3/44Yarns or threads characterised by the purpose for which they are designed
    • D02G3/448Yarns or threads for use in medical applications
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04BKNITTING
    • D04B21/00Warp knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
    • D04B21/10Open-work fabrics
    • D04B21/12Open-work fabrics characterised by thread material
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06BTREATING TEXTILE MATERIALS USING LIQUIDS, GASES OR VAPOURS
    • D06B9/00Solvent-treatment of textile materials
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M13/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
    • D06M13/10Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing oxygen
    • D06M13/184Carboxylic acids; Anhydrides, halides or salts thereof
    • D06M13/207Substituted carboxylic acids, e.g. by hydroxy or keto groups; Anhydrides, halides or salts thereof
    • D06M13/21Halogenated carboxylic acids; Anhydrides, halides or salts thereof
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M2101/00Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
    • D06M2101/02Natural fibres, other than mineral fibres
    • D06M2101/04Vegetal fibres
    • D06M2101/06Vegetal fibres cellulosic
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M23/00Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
    • D06M23/10Processes in which the treating agent is dissolved or dispersed in organic solvents; Processes for the recovery of organic solvents thereof
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00Medical; Hygiene
    • D10B2509/02Bandages, dressings or absorbent pads
    • D10B2509/022Wound dressings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2913Rod, strand, filament or fiber
    • Y10T428/2973Particular cross section
    • Y10T428/2975Tubular or cellular

Abstract

wound dressing for use in vacuum wound therapy comprising a wound contact layer which is an open structure comprising a yarn comprising gel-forming filaments or fibres, the structure having a pore or mesh size between 0.5 mm2 to 5.0 mm2.

Description

WOUND DRESSING FOR USE IN VACUUM THERAPY The present invention relates to a device and kit for treating a wound with a dressing and Vacuum.
Vacuum has been used to se blood flow to wound tissue and to remove exudate from the wound site. In general vacuum treatment uses a device comprising a cover for sealing about the outer perimeter of the wound, under which a vacuum is established to act on the wound e. The vacuum applied to the wound e accelerates healing of chronic wounds. A screen of open cell foam material or gauze is typically used under the cover to provide the space in which the vacuum is formed and to reduce tissue ingrowth. Sufficient vacuum is applied for a suitable duration to promote tissue ion in order to facilitate the closure of the wound. Suitable vacuum is between about 0.1 and 0.99 atmospheres. The vacuum can be substantially continuous or can be cyclic with the ation of vacuum for alternating periods of application and nonapplication.
Many common conventional and advanced wound contact dressings have shortcomings particularly for use in suction wound y. In an example, gauze and other similar flat fabric materials are commonly used as wound dressings. When gauze is in contact with a wound it becomes wet with exudate and collapses into the wound. New tissue growth can engulf the gauze making it difficult and painful to remove from the wound.
When foam is in contact with a wound and vacuum is applied, the foam can collapse and in-growth of tissue can occur into the collapsed cell structure of the foam. In order to overcome this problem relatively rigid perforated sheets have been used to t the wound. However, they are not sufficiently flexible and conformable to comfortably and adequately conform to wound surfaces that are often irregular in contour. A dressing having such an inflexible or rigid ured material or wound contact layer can cause unnecessary pain and discomfort to a patient.
In a vacuum wound dressing is described which is a fibrous blend or s al that forms a cohesive gel when wetted with wound exudate. The dressing is in the form of a non-woven fibrous mat.
A wound dressing for use in vacuum wound therapy preferably has some or all of the following characteristics and properties: it is porous to allow exudate to flow; it has pores or holes to enable the underlying tissue to feel the effects of tissue strain; it can be easily folded or scrunched to fill the wound site; if fibrous, it has minimal fibre loss into the wound; it presents the same material properties to the side of the wound as it does to the wound bed so that the wound contact surface is tent over the whole wound; it resists tissue th; it has sufficient wet strength to facilitate easy removal; it does not exert re on the wound bed on absorption of exudate; it is suitable for a range of sizes of wound and for various shapes and depths; it has minimal bioadhesion to minimise disruption to the wound bed on removal; it imposes beneficial strain on the tissue when suction is applied to it.
We have found that it is possible to e a rming wound dressing with many of the above desirable properties and which overcomes some of the problems of tissue ingrowth identified above while filling the wound and allowing exudate to flow out of the wound site when a vacuum is applied.
The discussion of the background to the invention ed herein including reference to documents, acts, materials, devices, articles and the like is included to n the context of the present invention. This is not to be taken as an admission or a suggestion that any of the material referred to was published, known or part of the common general knowledge in New Zealand or in any other country as at the priority date of any of the claims.
Accordingly, one aspect of the t invention provides a wound dressing for use in vacuum wound y comprising a wound contact layer which is an open structure comprising a yarn which ses gel-forming filaments or fibres, the structure having a pore or mesh size between 0.5 mm2 to 5.0 mm2. The porosity of the structure allows exudate to flow through it.
It has been found that strain imposed on the tissue by the vacuum is believed to stimulate new tissue growth and assist healing. The porosity present in the open structure of the dressing according to the invention is believed to facilitate the application of strain to the tissue of the wound.
The open structure can be in the form of a net knitted, woven or embroidered from a yarn comprising gel-forming nts or . By the term yarn is meant a thread or strand of continuous filament or staple fibres. Alternatively the open structure can be first knitted, woven or embroidered from a textile yarn which is then chemically modified to impart gel-forming properties to it. For instance, the yarn can be a cellulose yarn which is knitted or woven to form the open structure and is then chemically modified to give the fibres greater absorbency and gelling properties.
By gel g fibres is meant hygroscopic fibres which upon the uptake of wound exudate become moist slippery or gelatinous and thus reduce the tendency for the surrounding fibres to adhere to the wound. The gel forming fibres can be of the type which retain their ural integrity on absorbtion of exudate or can be of the type which lose their fibrous form and become a structureless gel. The gel forming fibres are preferably spun sodium carboxymethylcellulose fibres, chemically modified cellulosic fibres, pectin fibres, alginate fibres, chitosan fibres, hyaluronic acid fibres, or other polysaccharide fibres or fibres d from gums. The cellulosic fibres preferably have a degree of substitution of at least 0.05 substituted groups per e unit. The gel forming fibres preferably have an absorbency of at least 2 grams 0.9% saline solution per gram of fibre (as measured by the free swell absorbency method BS EN 13726-1:2002 Test methods for primary wound dressings – Part 1 : Aspects of absorbency, Method 3.2 free swell absorptive capacity).
Preferably the gel forming fibres have an absorbency of at least 10g/g as measured in the free swell absorbency method, more preferably between 15g/g and 25g/g.
The dressing may for ce comprise non gel forming fibres and in ular textile fibres such as Tencel, cotton or e and may comprise lycra or other elastic fibre. Preferably the e fibres have an absorbency of less than 10g/g as measured by the free swell method and more preferably less than 5 g/g.
The pore size of the dressing in part determines the strain placed on the wound when suction is applied. The strain is also ined by the uniformity of the dressing over the area treated.
The maximum strain and the uniformity of its application will therefore depend not only on the pore sixe of the open structure but also on the linear density of the yarn used to make the dressing. Maximum strain can be achieved by sing the pore size or increasing the yarn linear density. Uniformity is increased by decreasing the pore size and decreasing the yarn linear density. We have found that acceptable strain is placed on the wound where the structure has a pore size of between 0.5 mm2 to 5.0 mm2, preferably between 3.0 mm2 to 4.0 mm2 and the yarn has a linear y of 20 tex to 40 tex.
The open structure can be in the form of a net with yarn joined at intervals to form a set of meshes or the open ure can be knitted with a pore size as mentioned above.
An advantage of such an open structure is that it is easily folded or crumpled to fit the wound and pack the wound site. Due to the structure, the dressing still allows e to pass h it when a vacuum is applied to the wound even though the dressing may not be co-planar with the wound bed. The conformability of the open structure allows all parts of the wound to be contacted with a similar dressing structure so that for ce the sides of the wound are contacted by the open structure as well as the wound bed.
In a further aspect the present invention es a device for vacuum wound therapy comprising the wound dressing as described ; a source of vacuum situated to be ted from a wound bed by the wound dressing; and a vacuum sealing layer covering the wound dressing and adapted to retain relative vacuum in the wound contact layer.
The open structure of the dressing of the invention can be made by first forming a yarn of gelling fibres. This may be done in various ways. For example gel forming fibres, which are for instance any of those mentioned above or can be modified cellulose, or carboxymethyl cellulose or alginate, can be spun into yarns comprising various blends of gel-forming staple fibres and textile fibres. The spinning may be done by first carding the fibres in the blend and spinning a yarn from the carded blend.
We have found that particularly suitable yarns can be formed by rotor spinning or open end spinning. In such a process, staple gel-forming fibres are blended with textile fibres and carded to produce a continuous web. The web is condensed to produce a card sliver and then rotor spun. In rotor spinning, a high speed centrifuge is used to collect and twist dual fibres into a yarn. The yarns produced from this que have the characteristics of sufficient tensile strength to enable them to be further processed using knitting or weaving machinery.
Also described is a process for making a yarn comprising gel-forming fibres comprising the steps of: blending staple gel-forming fibres optionally with textile ; carding to form a continuous web; g the web to produce a ; and rotor ng to produce a yarn.
Yarns produced by this method preferably comprise from 30% to 100% by weight gel-forming fibres and 0% to 70% by weight textile fibres. More ably the yarns comprise from 50% to 100% by weight of gel-forming fibres with the e of textile fibres and most preferably from 60% to 100% by weight of gel-forming fibres.
The fibres present in the spun yarn preferably have a staple length of 30 to 60mm, more preferably 40 to 55mm and most preferably 45 to 55mm.
A yarn made according to the processes of the present invention need not contain textile fibres enabling structures to be produced which consist wholly of gel-forming fibres.
A g yarn can be produced using a spun yarn consisting of natural cellulose fibres or solvent spun cellulose staple fibres or a blend of cellulose fibres and other textile fibres or by using a filament yarn of t spun cellulose which is then converted to chemically modify the yarn to produce gelling properties. For example, Lyocell yarns can be used as a starting material and converted in a kier process to impart gel- forming behaviour to the yarn.
Yarns made according to the ses of the present invention preferably have a dry tensile strength of at least ex, preferably from 10 to 40 cN/tex and most preferably from 16 to 35 cN/tex as measured by British Standard ISO 2062 2009.
Alternatively the open structure of the dressing of the invention can be made by weaving using a textile yarn and the resulting fabric then converted to impart gel-forming behaviour to it to form an open structure of gel-forming fibres.
It is also possible to warp or weft knit an open structure using a e yarn such as Lyocell and then convert the resulting fabric to make the wound dressing of the invention. Further it is possible to embroider an open structure in textile yarn onto a support film which is then removed for instance by washing and the resulting structure converted to form an open structure comprising a yarn of gel-forming fibres.
In a further aspect the present invention provides a process for making the open structure comprising yarn of gel-forming fibres as described herein, the process including the steps of: embroidering an open ure having a pore or mesh seize between 0.5 mm2 to 5.0 mm2 in a e yarn on a soluble support film; removing the support film by dissolving it; and chemically modifying the structure of step (i) to give the yarn gel-forming properties to form the open structure comprising yarn of gel-forming fibres.
A preferred method of ting the yarns or s is described in WO 00/01425. For example the yarns or fabrics can be carboxymethylated by pumping a on fluid through the reaction vessel and therefore the cellulosic materials at 65°C for 90 minutes. The reaction fluid is a solution of an alkali (typically sodium hydroxide) and sodium monochloroacetate in industrial denatured alcohol. After the reaction time, the reaction is neutralised with acid and washed before being dried in a laboratory oven for 1 hour at 40°C.
Where the terms "comprise", "comprises", "comprised" or "comprising" are used in this specification (including the claims) they are to be interpreted as specifying the presence of the stated features, integers, steps or components, but not precluding the presence of one or more other es, integers, steps or components, or group thereof.
Preferred embodiments of the invention are illustrated in the drawings in which: Figure 1 is a graph showing tensile strengths for yarns according to the invention; Figure 2 shows open structures produced from a yarn comprising gel forming fibres in a relaxed, ly stretched out and wet and slightly stretched out state; Figure 3a shows a fabric knitted using Tencel warps and weft insertion of a yarn according to the invention in both dry and wet states; Figure 3b shows the locking in of one yarn by another for the fabrics in Figure 3a; Figure 4 shows an open structure ed by embroidering a textile yarn on a film, (a) showing the embroidered two d structure on a film, (b) showing the converted dry ure and (c) showing that ure wet; Figure 5 shows a locked in a warp knitted structure produced using HF-2011/250; Figure 6 shows a microscope image of Figure 5 g connecting yarns forming stitches within the pillar stitch; Figure 7 shows a ted woven structure in a dry state; Figure 8 shows the structure from Figure 7 but wet.
The invention is illustrated by the following examples.
Example 1 ~ Spinning Yarn from staple gel-forming fibres Lyocell fibres and carboxymethyl cellulose staple fibres in blends of 50:50, 60:40 and 70:30 ocell were made by carding on a Trutzschler cotton card and spinning the resulting sliver at a twist of 650 turns/meter.
Example 2 ~ Converting a textile yarn to a gel-forming yarn Yarns were converted in the laboratory using a mini kier. In both trials, staple and filament lyocell yarns were converted. The yarns used for the conversion were staple 33 Tex Tencel®; HF—2011/090; and 20 Tex filament l batches 1/051 (trial 1) and HF-2011/125 (trial 2). Tencel® is a g owned, trademarked brand of lyocell and the Tencel® yarn used was a spun staple yarn. The filament lyocell was supplied by Acelon chemicals and Fiber Corporation (Taiwan) via Offtree Ltd.
The advantages of ting a yarn are that complete cones of yarn could potentially be converted in one relatively simple s, and the processing of gelling fibres is avoided, thus reducing the number of processing steps required and damage to the fibres.
Trial 1 —— Yarn d Around Kier Core In this trial, Tencel® yarn was tightly wrapped around the perforated core of the kier using an electric drill to rotate the core and pull the yarn from the packages for speed.
This meant that the yarn was wrapped tightly around the core under tension.
The yam was converted by a process as described in WO 00/01425 in which carboxymethylation was carried out by pumping fluid through the kier and therefore the cellulosic materials at 65C for 90 minutes. The reaction fluid was a solution of an alkali (typically sodium hydroxide) and sodium monochloroacetate in industrial denatured alcohol. After the reaction time, the reaction was neutralised with acid and washed before being dried in a laboratory oven for 1 hour at 40 C.
The conversion was successful and both staple and filament g yarns were produced; HF-2011/103 and HF-ZOI 1/105 respectively. Due to the tight and uneven wrapping of the staple yarn around the core, it had to be removed using a scalpel which left multiple short lengths (approximately 14cm) of the converted yarn.
Trial 2 — Small Yarn Hanks The aim of the second trial was to produce longer s of converted yarns for testing hence a small hank was made of each the staple and t lyocell yarns by hand and these were placed between layers of fabric for the conversion.
The yarn was converted by placing the hanks in a kier and. converting to form a gel- forming fibre yarn as described above for Trial 1.
The conversion was successful and both staple and filament gelling yarns were produced; HF-2011/146 and HF-201 1/147 respectively.
Yarn y Sample HF# Gelling Yarns 50:50 Spun staple gelling yarn HF-2011/001 60:40 Spun staple gelling yarn HF-2011/088 70:30 Spun staple g yarn HF-2011/108 Converted staple yarn (trial 1) HF-2011/103 Converted filament yarn (trial 1) 1/105 Converted staple yarn (trial 2) HF-201 1/ 146 Converted filament yarn (trial 2) HF-ZOl 1/147 Non-Gelling Yarns Staple Tencel® HF-2011/090 Filament lyocell (sample) HF-2011/051 Filament lyocell (bulk) HF-2011/125 Results from Examples 1 and 2 With the exception of HF-ZOll/OSI, all of the yarns were tested for wet and dry tensile strength. tions were made to the standard method BS EN ISO 2062:2009; “Textiles ~ Yarns from packages: Determination of single-end breaking force and elongation at break using constant rate of extension (CRE) tester”. A Zwick tensile testing machine was used with a gauge length of 100mm. The test uses a 100N or 20N» liad cell to exert a constant rate of extension on the yarn until the breaking point is reached. Wet tensile testing was measured by wetting the samples with 0.2m] of solution A in the central 3 to 4cm of each yarn and leaving for 1 minute. The wetted sample was then placed in the jaws of the Zwick and d shut. Tensile strength was tested as the yarns produced need to be strong enough to withstand the tensions and forces applied during knitting, weaving and embroidery.
Tensile Strength The results showed that all of the yarns Were stronger when they were dry than when they were wet, with 1/108, the 70:30 gelling yarn, showing the t tional strength decrease.
Of the yarns tested, HF-2011/ 108 was the weakest yarn both when wet and dry with tensile strengths of 12.4 and Tex respectively, despite ning 30% lyocell fibres. As this was the weakest yarn, but it was sfully weft knitted; HF-2011/120 and woven; HF-2011/l69 into fabrics, it is believed that all of the other yarns would also be strong enough to be converted into fabrics.
Both approaches successfully produced gelling yarns.
Example 3 Producing open structures from gel-forming yarn A yarn was produced with a 2/12s worsted count consisting of 60% CMC fibres and 40% viscose fibres, each with a staple length of ~40mm and the fibres were blended at the fibre stage. The yarn was produced using a worsted system and two 12 count strands were plied together. When dry, the yarn felt soft and the plying was clear as the two strands wrapped around each other. On wetting with Solution A, the yarn gelled and swelled to form a thicker yarn, and the plying became more pronounced.
A sample was made using this yarn on a warp knitting/stitch bonding machine and was hydrated with on A.
The sample structure was d with Tencel warp yarns and gelling yarn wefts in a net- like arrangement, which is especially visible when the structure is opened by gentle stretching, as shown in figure 2. On wetting the structure gels slightly and feels wet but it holds its open shape well.
Example 4 A yarn comprising gel forming fibres was produced by the method of example 3. Using this yarn a fabric was knitted using Tencel warps and gelling yarn weft insertion. The weft yarns were inserted in such a way that they became locked in due to the pattern of knitting. This material has the weft yarn path notation of 0-1/1-1/1-2/2-3/3—2/2-1/1-2//.
The material felt quite thin and when wet, it gels but seems to hold fluid on its surface.
Example 5 Producing open structures from a textile yarn Using a Tajima TMEX-ClZOl embroidery machine s were produced on a PVA film from l thread (on the bobbin and as the top thread).
Thread = Gfitermann 120 Tex lyocell thread from Tony Slade (T.S. Sewing Supplies) Software = Wilcom ES Programme name = honeycomb Number of stitches = 12,369 per 2 layers Backing film = Soluble PVA film Speed used = lZOOrpm The film was removed by washing in warm tap water in a sink using lots of agitation until the film looked to have been removed. The s were air dried on the bench The fabrics were converted by a s as described in WO 00/01425 and detailed in Example 2.
Example 6.
Warp knitting to produce a locked in structure.
To produce a fully locked in structure, a warp d fabric without any weft inlays is preferred. In the ing example (figure 5) .a fabric has been formed from a set of 4 pillar stitches, the yarn then underlaps to the adjacent set of pillar stitches and continues to form pillar stitches on this needle before underlapping back to the initial needle. Eg a typical yarn path on for the simplest type of this fabric would be 0-2/2-1/2-1/2-0/0- l/0-1//. By using 2 sets of warp ends within one set of chain stitch alternating the yarn used for each stitch stops the structure being able to be lled easily. This structure could be complicated by using more needles within the design or using on warp beams to underlap in te directions. The fabric produced is a locked in structure as the each knitted stitch is secured by a knitted stitch of another yarn end stopping the structure from unravelling and the threads going perpendicular to the pillar stitches also form loops within the structure, as shown in figure 6, ensuring that these are locked in.
Example 7 Weaving Open plain weave structures have been produced on a Northrop loom, using a g yarn previously described, HF-2011/108 to e fabric HF-2011/169. And by using a Tencel spun yarn HF-2011/O90 and converting at the fabric stage, to produce fabric HF- 2011/136. The structure uses a warp density of 7.8 ends/cm and a weft density of 5.5 picks/cm.
Figure 7 shows HF-2011/l36, the sample converted at the fabric stage using the lab conversion process as previously described. This produced an open structure that is thin and flexible in its dry form. When wet this structure is less stable and bunches, but forms a gelled structure as shown in figure 8.
Example 8 To produce a locked in woven sample, leno weaving is used. Leno weaving is a form of weaving in which warp threads are made to cross one another between the picks. As the warp yarns cross one another they are able to hold the weft yarns in place so little movement occurs within the ure. When the sample is cut theoretically the yarns should not be able to be removed as, the free end is held in place by le warps within the rest of the structure. The leno can be applied to all or some of the yarns within the fabric.

Claims (9)

The claims defining the invention are as follows:
1. A wound dressing for use in vacuum wound therapy comprising a wound contact layer which is an open structure comprising a yarn comprising gel-forming filaments or fibres, the ure having a pore or mesh size between 0.5 mm2 to 5.0 mm2. 5
2. A wound dressing as claimed in claim 1 wherein the pore or mesh size of the open structure is between 3.0 mm2 to 4.0 mm2.
3. A wound dressing as claimed in claim 1 or claim 2 n the yarn has a linear density of 20 tex to 40 tex.
4. A wound dressing as claimed in any one of the preceding claims wherein the open 10 structure is knitted.
5. A wound dressing as claimed in any one of claims 1 to 3 wherein the dressing is in the form of a net with yarn joined at als to form a set of meshes.
6. A device for vacuum wound therapy comprising: the wound dressing of any one of the preceding claims; 15 a source of vacuum ed to be separated from a wound bed by the wound dressing; and a vacuum sealing layer covering the wound dressing and adapted to retain relative vacuum in the wound contact layer.
7. A process for making the open ure comprising yarn of gel-forming fibres as claimed in any one of claims 1 to 5, the process comprising the steps of: 20 (i) embroidering an open structure having a pore or mesh size between 0.5 mm2 to 5.0 mm2 in a textile yarn on a soluble support film; (ii) removing the support film by ving it; and (iii) chemically modifying the structure of step (i) to give the yarn gel-forming properties to form the open structure comprising yarn of gel-forming fibres. 25
8. A process as claimed in claim 7 wherein the chemical modification is carboxymethylation using a reaction fluid of a solution of an alkali and sodium monochloroacetate in industrial denatured alcohol.
9. A process as d in claim 7 or claim 8 wherein the tensile strength of the yarn is at least 10cN/tex.
NZ626694A 2011-12-01 2012-11-29 Wound dressing for use in vacuum therapy NZ626694B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1120693.5A GB201120693D0 (en) 2011-12-01 2011-12-01 Wound dressing for use in vacuum therapy
GB1120693.5 2011-12-01
PCT/GB2012/052950 WO2013079947A1 (en) 2011-12-01 2012-11-29 Wound dressing for use in vacuum therapy

Publications (2)

Publication Number Publication Date
NZ626694A NZ626694A (en) 2016-04-29
NZ626694B2 true NZ626694B2 (en) 2016-08-02

Family

ID=

Similar Documents

Publication Publication Date Title
AU2012343581B2 (en) Wound dressing for use in vacuum therapy
JP4267694B2 (en) Woven wound dressing and method for producing the same
CA2250473C (en) Composite fibres, wound dressings incorporating such fibres and a method for making same
US20150282991A1 (en) High hygroscopic wound dressing and preparation method and use thereof
CN112626873A (en) Glass fiber warp-knitted medical bandage
US20210137742A1 (en) High hygroscopic wound dressing and preparation method and use thereof
NZ626694B2 (en) Wound dressing for use in vacuum therapy
CN111349996A (en) Yarn, fabric and cleaning towel for terry spinning
NZ723782B2 (en) A yarn comprising gel-forming filaments or fibres
NZ626695B2 (en) A yarn comprising gel-forming filaments or fibres